Research at NCI-Frederick

Scientists at NCI-Frederick, part of the National Institutes of Health (NIH), direct research into the causes, treatment, and prevention of cancer, AIDS, and related diseases. From basic research into the molecular mechanisms of carcinogenesis to pre-clinical investigation of potential new treatments, scientists at NCI-Frederick are studying the origins of cancer—the genes, proteins, and signals involved in initiation—and identifying possible targets to treat or prevent the disease. In addition to the many NCI labs located here, the Frederick campus also serves as a major biotechnology resource center for NCI/NIH. The Advanced Technology Program is developing new technologies in areas such as proteomics and imaging, while the Advanced Biomedical Computing Center provides fully integrated, high performance, scientific computing support. Visit the links below to learn more.

Scientists – A comprehensive index of senior scientists working at NCI-Frederick.

Labs/Branches/Programs – An index of all NCI/NIH scientific programs and groups located on the Frederick campus.

Biotechnology Resources – Information on the NCI/SAIC Research Technology Program and other core resources.

Faculties & Interest Groups – A directory of NCI’s intramural research faculties as well as various NCI/NIH scientific interest groups.

Center for Cancer Research (CCR) – The CCR is the largest research component of NCI’s Intramural Program. Many of Center’s research laboratories and programs are located on the Frederick campus.

Developmental Therapeutics Program (DTP) – The DTP is the NCI’s drug discovery and development arm. The Developmental Therapeutics Program plans, conducts, and facilitates the development of new therapeutic agents for cancer and AIDS. DTP is a major research resource; the Program provides Web-accessible data and tools, vialed and plated compounds, tumor cells, animals, and Investigational New Drug (IND)-directed studies.